Item 5.02.		Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers

(e) On January 24, 2007, the compensation committee (the “Committee”) of the Board of Directors of Cadence Pharmaceuticals, Inc. (the “Company”) established performance goals for the payment of bonuses for the 2007 fiscal year under the Company’s 2006 equity incentive award plan (the “Plan”). The Committee determined that the individual bonus awards for 2007 would be based on eight performance goals. The performance goals relate to the following categories: (i) advancement of the Company’s clinical development programs, (ii) achievement of business development objectives, and (iii) achievement of certain corporate organizational and infrastructure objectives.

     The above description of the Company’s 2007 bonus program under the Plan does not purport to be complete and is qualified in its entirety by reference to the Plan, a copy of which was filed by the Company as Exhibit 10.5 to its Registration Statement on Form S-1, as amended (No. 333-135821).

     Additional information regarding compensation of the named executive officers, including the factors considered by the Committee in determining actual compensation, will be included in the Company’s 2007 proxy statement.